Parallel Advisors, LLC - CTI BIOPHARMA CORP ownership

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$491
+148.0%
117
+254.5%
0.00%
Q4 2022$19833
+13.8%
0.00%
Q2 2022$0290.00%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2023.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders